Hexahydrocannabinol Pharmacology, Toxicology, and Analysis: The First Evidence for a Recent New Psychoactive Substance
- PMID: 37357519
- PMCID: PMC10616920
- DOI: 10.2174/1570159X21666230623104624
Hexahydrocannabinol Pharmacology, Toxicology, and Analysis: The First Evidence for a Recent New Psychoactive Substance
Abstract
Background: During the last two years, hexahydrocannabinol (HHC), the hydrogenated derivative of tetrahydrocannabinol has been freely sold by internet websites as a "legal" replacement to THC and cannabis in a range of highly attractive branded and unbranded products, some of which are sold as "legal highs". Potentially, there could be a large demand for HHC products by individuals in Europe and internationally.
Methods: Studies reporting HHC pharmacology, toxicology and analysis were identified from Pubmed and Scopus databases, and official international organizations' websites were considered.
Results: HHC showed the effects of the typical cannabinoid on the central nervous system, with lower potency than Δ9-THC. A few studies highlighted that 9(R)-HHC is more potent than 9(S)-HHC. This molecule showed an affinity for cannabinoid receptor CB1 both in vitro and in vivo, suggesting a possible therapeutic effect in several pathologies. However, the affinity for the CB1 receptor suggests a possible addiction potential, inducing the users to misuse it. Since actual intoxication cases have not yet been reported, the HHC harmful potential was not described, probably due to the lack of effective analytical methods to detect HHC in biological matrices. Conversely, different analytical assays were developed and validated to separate HHC epimers in natural and non-natural sources.
Conclusion: Similarly to other NPS, the HHC represents a cheaper alternative to the controlled Δ9-THC. Its monitoring is a crucial challenge for toxicological and forensic purposes. To this concern, it is essential to further investigate HHC to support health providers in the identification of related intoxications.
Keywords: Hexahydrocannabinol; cannabinoids; new psychoactive substances; phytocannabinoids; synthetic cannabinoids.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Conflict of interest statement
The authors declare no conflict of interest, financial or otherwise.
Figures
Similar articles
-
Saturated Cannabinoids: Update on Synthesis Strategies and Biological Studies of These Emerging Cannabinoid Analogs.Molecules. 2023 Sep 4;28(17):6434. doi: 10.3390/molecules28176434. Molecules. 2023. PMID: 37687263 Free PMC article. Review.
-
In vitro activation of the CB1 receptor by the semi-synthetic cannabinoids hexahydrocannabinol (HHC), hexahydrocannabinol acetate (HHC-O) and hexahydrocannabiphorol (HHC-P).Drug Test Anal. 2025 Apr;17(4):487-493. doi: 10.1002/dta.3750. Epub 2024 Jun 19. Drug Test Anal. 2025. PMID: 38894658 Free PMC article.
-
Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays-and how this matters for the harm potential of seized drugs.Arch Toxicol. 2024 Aug;98(8):2619-2630. doi: 10.1007/s00204-024-03769-4. Epub 2024 May 12. Arch Toxicol. 2024. PMID: 38735004
-
Synthesis and pharmacological activity of the epimers of hexahydrocannabinol (HHC).Sci Rep. 2023 Jul 8;13(1):11061. doi: 10.1038/s41598-023-38188-5. Sci Rep. 2023. PMID: 37422571 Free PMC article.
-
Hexahydrocannabinol and closely related semi-synthetic cannabinoids: A comprehensive review.Drug Test Anal. 2024 Feb;16(2):127-161. doi: 10.1002/dta.3519. Epub 2023 Jun 2. Drug Test Anal. 2024. PMID: 37269160 Review.
Cited by
-
Preliminary pharmacokinetic and psychophysical investigations after controlled oral and inhalative consumption of hexahydrocannabinol (HHC).Sci Rep. 2025 Mar 24;15(1):10086. doi: 10.1038/s41598-025-93931-4. Sci Rep. 2025. PMID: 40128283 Free PMC article.
-
Hexahydrocannabinol: pharmacokinetics, systemic toxicity, and acute behavioral effects in Wistar rats.Int J Neuropsychopharmacol. 2025 Aug 1;28(8):pyaf041. doi: 10.1093/ijnp/pyaf041. Int J Neuropsychopharmacol. 2025. PMID: 40643195 Free PMC article.
-
QuEChERS Extraction and Simultaneous Quantification in GC-MS/MS of Hexahydrocannabinol Epimers and Their Metabolites in Whole Blood, Urine, and Oral Fluid.Molecules. 2024 Jul 22;29(14):3440. doi: 10.3390/molecules29143440. Molecules. 2024. PMID: 39065018 Free PMC article.
-
Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study.Pharmaceuticals (Basel). 2024 Feb 15;17(2):249. doi: 10.3390/ph17020249. Pharmaceuticals (Basel). 2024. PMID: 38399464 Free PMC article.
-
Saturated Cannabinoids: Update on Synthesis Strategies and Biological Studies of These Emerging Cannabinoid Analogs.Molecules. 2023 Sep 4;28(17):6434. doi: 10.3390/molecules28176434. Molecules. 2023. PMID: 37687263 Free PMC article. Review.
References
-
- EMCDDA technical expert meeting on hexahydrocannabinol (HHC) and related cannabinoids. EMCDDA. 2022. Available from: https://www.emcdda.europa.eu/news/2022/emcdda-technical-expert-meeting-h....
-
- Casiraghi G., Cornia M., Casnati G., Fava G.G., Belicchi M.F. A one-step highly stereocontrolled synthesis of (–)- and (+)-hexahydrocannabinol and related compounds. J. Chem. Soc. Chem. Commun. 1986;98(3):271–273. doi: 10.1039/C39860000271. - DOI
-
- Ujváry I. HHC and related cannabinoids. Med. Cannabis Cannabinoids. 2022;5:159–198. doi: 10.1159/000527113. - DOI
-
- Adams R., Smith C.M., Loewe S. Tetrahydrocannabinol homologs and analogs with marihuana activity X1. J. Am. Chem. Soc. 1941;63(7):1973–1976. doi: 10.1021/ja01852a053. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources